Hypogonadism, ADAM, and hormone replacement

Therapeutic Advances in Urology

Volumn 2, Issue 3, 2010, Pages 99-104

  Pinsky, Michael R ^a   Hellstrom, Wayne J G ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

androgen deficiency; hypogonadism; testosterone deficiency syndrome; testosterone replacement

Indexed keywords

ANDROGEN; CLOMIFENE; HORMONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TESTOPEL; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

AGING; ANDROGEN DEFICIENCY; ANDROGEN DEFICIENCY OF THE AGING MALE; ANDROGEN THERAPY; BODY COMPOSITION; COGNITION; ERECTILE DYSFUNCTION; FATIGUE; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOPHYSIS; MALE INFERTILITY; PRIORITY JOURNAL; REVIEW; SEXUAL FUNCTION; SUBSTITUTION THERAPY; TESTOSTERONE BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

EID: 79551699278     PISSN: 17562872     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756287210369805     Document Type: Article

References (32)

1. Allan, C.A. and McLachlan, R.I. (2004) Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol 60: 653-670.
2. American Society for Reproductive Medicine Practice Committee (ASRMPC) (2008) Androgen deficiency in the aging male. Fertil Steril 90: S83-S87.
3. Basaria, S. (2008) Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. J Androl 29: 534-539.
4. Bassil, N., Alkaade, S. and Morley, J.E. (2009) The benefits and risks of testosterone replacement therapy: a review. Therapeut Clin Risk Manage 5: 427-448.
5. Boyanov, M.A., Boneva, Z. and Christov, V.G. (2003) Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 6: 1-7.
6. Cavender, R.K. and Fairwall, M. (2009) Subcutaneous testosterone pellet implant (Testopel®) therapy for men with testosterone deficiency syndrome: a single-site retrospective safety analsysis. J Sex Med 6: 3177-3192.
7. Ding, E.L., Song, Y., Malik, V.S. and Liu, S. (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295: 1288-1299.
8. Feldman, H.A., Longcope, C., Derby, C.A., Johannes, C.B., Araujo, A.B., Coviello, A. et al. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589-598.
9. Grossmann, M., Thomas, M.C., Panagiotopoulos, S., Macisaac, R., Clarke, S.J., Zajac, G. et al. (2008) Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 93: 1834-1840.
10. Hak, A.E., Witteman, J.C., de Jong, F.H., Geerlings, M.I., Hofman, A. and Pols, H.A. (2002) Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 87: 3632-3639.
11. Harman, S.M., Metter, E.J., Tobin, J.D., Pearson, J. and Blackman, M.R. (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86: 724-731.
12. Janowsky, J.S. (2006) The role of androgens in cognition and brain aging in men. Neuroscience 138: 1015-1020.
13. Kapoor, D., Goodwin, E., Channer, K.S. and Jones, T.H. (2006) Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154: 899-906.
14. Khera, M. and Lipshultz, L.I. (2007) The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am 34: 549-553, vi.
15. Makinen, J.I., Perheentupa, A., Irjala, K., Pollanen, P., Makinen, J., Huhtaniemi, I. et al. (2008) Endogenous testosterone and serum lipids in middle-aged men. Atherosclerosis 197: 688-693.
16. Michael, H., Harkonen, P.L., Vaananen, H.K. and Hentunen, T.A. (2005) Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 20: 2224-2232.
17. Moffat, S.D., Zonderman, A.B., Metter, E.J., Blackman, M.R., Harman, S.M. and Resnick, S.M. (2002) Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 87: 5001-5007.
18. Moffat, S.D., Zonderman, A.B., Metter, E.J., Kawas, C., Blackman, M.R., Harman, S.M. et al. (2004) Free testosterone and risk for Alzheimer disline ease in older men. Neurology 62: 188-193.
19. Moore, C., Huebler, D., Zimmermann, T., Heinemann, L.A., Saad, F. and Thai, D.M. (2004) The Aging Males– Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 46: 80-87.
20. Morgentaler, A. (2007) Testosterone replacement therapy and prostate cancer. Urol Clin North Am 34: 555-563.
21. Morley, J.E., Charlton, E., Patrick, P., Kaiser, F.E., Cadeau, P., McCready, D. et al. (2000) Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49: 1239-1242.
22. Mulhall, J.P., Valenzuela, R., Aviv, N. and Parker, M. (2004) Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction. Urology 63: 348-352; discussion 352-343.
23. Ohl, D. and Quallich, S. (2006) Clinical hypogonadism and androgen replacement therapy: an overview. Urol Nurs 26: 253-259.
24. Page, S.T., Amory, J.K., Bowman, F.D., Anawalt, B.D., Matsumoto, A.M., Bremner, W.J. et al. (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90: 1502-1510.
25. Page, S.T., Bremner, W.J., Clark, R.V., Bush, M.A., Zhi, H., Caricofe, R.B. et al. (2008) Nanomilled oral testosterone plus dutasteride effectively normalizes serum testosterone in normal men with induced hypogonadism. J Androl 29: 222-227.
26. Rosario, E.R., Chang, L., Stanczyk, F.Z. and Pike, C.J. (2004) Age-related testosterone depletion and the development of Alzheimer disease. JAMA 292: 1431-1432.
27. Ramsden, M., Nyborg, A.C., Murphy, M.P., Chang, L., Stanczyk, F.Z., Golde, T.E. et al. (2003) Androgens modulate beta-amyloid levels in male rat brain. J Neurochem 87: 1052-1055.
28. Schiff, J.D., Ramirez, M.L. and Bar-Chama, N. (2007) Medical and surgical management male infertility. Endocrinol Metab Clin North Am 36: 313-331.
29. Shabsigh, A., Kang, Y., Shabsigh, R., Gonzalez, M., Liberson, G., Fisch, H. et al. (2005) Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med 2: 716-721.
30. Smith, M.R., Finkelstein, J.S., McGovern, F.J., Zietman, A.L., Fallon, M.A., Schoenfeld, D.A. et al. (2002) Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87: 599-603.
31. Taylor, F. and Levine, L. (2009) Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost. J Sex Med 7: 269-276.
32. Wang, C., Swerdloff, R.S., Iranmanesh, A., Dobs, A., Snyder, P.J., Cunningham, G. et al. (2000) Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85: 2839-2853.